Related Experiment Video
Updated: Nov 23, 2025

10:58
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
7.8K
Advances in Oral Subunit Vaccine Design
Hans Van der Weken1, Eric Cox1, Bert Devriendt1
1Department of Virology, Parasitology and Immunology, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium.
Vaccines
|December 30, 2020
Summary
Oral vaccines are crucial for inducing intestinal secretory IgA (SIgA) immunity against gut pathogens. Overcoming the challenging gastrointestinal environment and immune tolerance is key for developing effective oral subunit vaccines.
Area of Science:
- Immunology
- Vaccinology
- Gastroenterology
Background:
- Pathogens frequently invade hosts via the intestinal surface, necessitating robust intestinal secretory IgA (SIgA) responses for protection.
- Oral vaccination is the most effective strategy for inducing SIgA, yet faces significant challenges in vaccine development.
Purpose of the Study:
- To review recent advancements in oral vaccine design aimed at overcoming gastrointestinal barriers and inducing potent gut immunity.
- To highlight strategies for developing next-generation oral subunit vaccines.
Main Methods:
- Discussion of challenges in oral vaccine delivery, including degradation in the gastrointestinal tract and immune tolerance.
- Exploration of strategies such as protective delivery systems, mucosal adjuvants, and targeted delivery to immune cells.
Main Results:
- Several strategies have been developed to protect oral vaccine antigens from degradation and enhance their uptake by gut-associated lymphoid tissues.
- Adjuvants and targeting approaches are crucial for overcoming the gut's tolerogenic environment and eliciting strong immune responses.
Conclusions:
- Developing effective oral subunit vaccines requires a combination of strategies to protect antigens, enhance immunogenicity, and overcome gut-specific immune challenges.
- Future oral vaccine design must integrate solutions for antigen stability, targeted delivery, and immune modulation to achieve robust gut immunity.
Related Concept Videos
Vaccinations
49.4K
Overview
49.4K
Microorganisms in Medicine and Therapeutics
679
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
679
Cancer Vaccines
628
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
628

